Skip to main content
. 2013 Oct 16;2(6):793–802. doi: 10.1002/cam4.147

Figure 4.

Figure 4

ADAM17 suppression reduces tumor burden in vivo. (A) Images show the dissected tumors and (B) percentage of tumor incidence in mice that were injected with UM-SCC-14A cells that had been transduced with scrambled shRNA or ADAM17 shRNA and grown under adherent conditions (*P ≤ 0.05).